Darryl Cohen had “begun working with certain medical professionals” and a non-profit dedicated to sentencing mitigation, his defense lawyers said.

CNBC’s Brian Sullivan breaks down Morgan Stanley’s bold forecast for humanoid robots.

Morgan Stanley said the next chapter of the SpaceX story is its role in converting energy into intelligence through physical robots.

Investing.com -- Morgan Stanley has asked other banks to purchase portions of a $3 billion loan that finances Royal Caribbean Cruises

Bill Baruch, founder and president of Blue Line Capital, joins CNBC’s 'Halftime Report' to explain his latest portfolio moves.

Morgan Stanley cut its Apple price target to $355 despite raising revenue forecasts, citing softer iPhone pricing and rising memory chip costs squeezing profit margins.

Morgan Stanley cut its Apple price target to $355 despite raising revenue forecasts, citing softer iPhone pricing and rising memory chip costs squeezing profit margins.

Morgan Stanley increased their price target on Regeneron Pharmaceuticals from $758.00 to $779.00 and gave the stock an "equal weight" rating in a research note on Wednesday.

Morgan Stanley says Constellation Brands (STZ) beat estimates on shipments and margins, but beer demand is weak.

Morgan Stanley dropped their price objective on shares of Amgen from $362.00 to $359.00 and set an "equal weight" rating on the stock in a research report on Wednesday.

Morgan Stanley dropped their price objective on shares of Gilead Sciences from $165.00 to $163.00 and set an "overweight" rating on the stock in a report on Wednesday.